Literature DB >> 9632624

Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines.

S I Becker1, R Wang, R C Hedstrom, J C Aguiar, T R Jones, S L Hoffman, M J Gardner.   

Abstract

Immunization of mice with DNA vaccines encoding the full-length form and C and N termini of Plasmodium yoelii merozoite surface protein 1 provided partial protection against sporozoite challenge and resulted in boosting of antibody titers after challenge. In C57BL/6 mice, two DNA vaccines provided protection comparable to that of recombinant protein consisting of the C terminus in Freund's adjuvant.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9632624      PMCID： PMC108371     

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  24 in total

1.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

Authors:  P Panina-Bordignon; A Tan; A Termijtelen; S Demotz; G Corradin; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

2.  Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.

Authors:  J H Tian; S Kumar; D C Kaslow; L H Miller
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.

Authors:  J M Burns; W R Majarian; J F Young; T M Daly; C A Long
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

4.  An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.

Authors:  C J Luke; K Carner; X Liang; A G Barbour
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

5.  Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine.

Authors:  J H Tian; L H Miller; D C Kaslow; J Ahlers; M F Good; D W Alling; J A Berzofsky; S Kumar
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

6.  Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.

Authors:  R Wang; Y Charoenvit; T M Daly; C A Long; G Corradin; S L Hoffman
Journal:  Immunol Lett       Date:  1996-11       Impact factor: 3.685

7.  Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection.

Authors:  M A Herrera; F Rosero; S Herrera; P Caspers; D Rotmann; F Sinigaglia; U Certa
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

8.  Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.

Authors:  B Enders; E Hundt; B Knapp
Journal:  Mem Inst Oswaldo Cruz       Date:  1992       Impact factor: 2.743

9.  A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.

Authors:  S P Chang; S E Case; W L Gosnell; A Hashimoto; K J Kramer; L Q Tam; C Q Hashiro; C M Nikaido; H L Gibson; C T Lee-Ng; P J Barr; B T Yokota; G S Hut
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria.

Authors:  T M Daly; C A Long
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422
View more
  12 in total

1.  Infectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite: implications for sporozoite vaccine trials.

Authors:  J A Vaughan; L F Scheller; R A Wirtz; A F Azad
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Genetic immunization of BALB/c mice with a plasmid bearing the gene coding for a hybrid merozoite surface protein 1-hepatitis B virus surface protein fusion protects mice against lethal Plasmodium chabaudi chabaudi PC1 infection.

Authors:  G Wunderlich; I C Moura; H A del Portillo
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Characterization of a Plasmodium falciparum erythrocyte-binding protein paralogous to EBA-175.

Authors:  D C Mayer; O Kaneko; D E Hudson-Taylor; M E Reid; L H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

4.  Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii.

Authors:  Yuko Kawabata; Heiichiro Udono; Kiri Honma; Masakatsu Ueda; Hiroshi Mukae; Jun-Ichi Kadota; Shigeru Kohno; Katsuyuki Yui
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

5.  Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques.

Authors:  W O Rogers; J K Baird; A Kumar; J A Tine; W Weiss; J C Aguiar; K Gowda; R Gwadz; S Kumar; M Gold; S L Hoffman
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.

Authors:  D L Narum; S Kumar; W O Rogers; S R Fuhrmann; H Liang; M Oakley; A Taye; B K Sim; S L Hoffman
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

7.  Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1.

Authors:  D C Ghislaine Mayer; Joann Cofie; Lubin Jiang; Daniel L Hartl; Erin Tracy; Juraj Kabat; Laurence H Mendoza; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-11       Impact factor: 11.205

8.  Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45.

Authors:  Diana Haddad; Jorge Maciel; Nirbhay Kumar
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

9.  Polymorphism in the Plasmodium falciparum erythrocyte-binding ligand JESEBL/EBA-181 alters its receptor specificity.

Authors:  D C Ghislaine Mayer; Jian-Bing Mu; Osamu Kaneko; Junhui Duan; Xin-zhuan Su; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

10.  DNA-Loaded Cationic Liposomes Efficiently Function as a Vaccine against Malarial Proteins.

Authors:  Wesley L Fotoran; Rachele Santangelo; Beatriz N M de Miranda; Darrell J Irvine; Gerhard Wunderlich
Journal:  Mol Ther Methods Clin Dev       Date:  2017-08-23       Impact factor: 6.698
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.